Drug therapy efficacy for the syndrome of chronic pelvic pain relapses in perinatal endometriosis

Comparative analysis of drug therapy efficacy for the syndrome of chronic pelvic pain relapses in perinatal endometriosis has been presented: it included dienogest monotherapy and combined interleukin-2 (il-2) and dienogest therapy. It has been proved that dienogest in combination with Interleukin-2 (ronkoleukin) followed by supportive therapy with dienogest-containing oral contraceptives (DCOK) is more effective for arresting pain syndrome, eliminating psycho-emotional disorders and preventing relapses.